Rasamin Tablet (Rasagiline Mesylate)

Adult dose

This medicine is administered orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended starting dose for patients taking levodopa is 0.5 mg once daily. If the medicine is well tolerated but an adequate clinical response is not achieved, the dose may be increased to 1 mg once daily. This medicine may be taken with or without food.

This medication should not be used by patients who are allergic to certain ingredients. Patients who are taking other MAO inhibitors or certain natural medicines, or who have recently stopped taking them, should also not use this medication. Patients taking medications such as pethidine, tramadol, or dextromethorphan should not combine them with this medication. This medication is not administered to patients with moderate or severe liver dysfunction. When taking this medication, various side effects such as headaches, dizziness, nausea, insomnia, and arthralgia may occur, so caution is required. Particularly in Parkinson's disease patients, hallucinations, confusion, and movement disorders may occur. This medication can cause blood pressure fluctuations, so it is important to monitor blood pressure regularly. When used with dopamine-related treatments, symptoms such as impulse control disorders or excessive sleepiness may arise, so caution is advised. Ensure to check for drowsiness or sudden sleep episodes when engaging in activities requiring concentration, such as driving or operating machinery. Caution is necessary when using this medication during pregnancy or lactation, especially as it may affect breastfeeding in nursing women. Dose adjustments or careful usage is required for children or elderly patients over 65 years of age. Serious side effects may occur with overdose, so immediate consultation with healthcare personnel is necessary, as there are no specific antidotes, and treatment directed at symptoms is needed. This medication should be stored in a cool place, protected from direct sunlight, and out of reach of children, and transferring to other containers should be avoided.

• Influenza
• skin cancer
• leukopenia
• allergy
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly sealed container to protect it from air and moisture. The appropriate storage temperature is between 1 degree and 25 degrees Celsius in a cool place.

Appearance

White round tablets

Package unit

30 tablets/PTP [(10 tablets/PTP x 3)]